These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6412785)

  • 1. [Importance of recent advances in our understanding of antimicrobial cell-mediated immunity to the International Union for the Prevention of Tuberculosis].
    Rook GA
    Bull Int Union Tuberc; 1983 Mar; 58(1):62-72. PubMed ID: 6412785
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contemporary approach to the immunology of tuberculosis].
    Dudvarski-Ilić A
    Med Pregl; 2004; 57 Suppl 1():29-31. PubMed ID: 15686218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cavity formation and cellular immunity].
    Maeda H; Yamamura Y; Ogawa A; Tomiya I; Tahara T
    Kekkaku; 1980 Oct; 55(10):461-5. PubMed ID: 6785510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Certain indicators of cellular and humoral immunity in experimental isolated tuberculous lesions in the lungs].
    Averbakh MM; Chekareva GA; Lindner DP
    Probl Tuberk; 1976 Nov; (11):71-6. PubMed ID: 828259
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA vaccines against tuberculosis.
    Lowrie DB
    Curr Opin Mol Ther; 1999 Feb; 1(1):30-3. PubMed ID: 11249680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The structural and functional status of the immune system in pre-school children infected with Mycobacterium tuberculosis].
    Kurtasova LM; Prakhin EI; Shakina NA; Gorbacheva NN; Leshchenko OA
    Probl Tuberk Bolezn Legk; 2004; (1):31-2. PubMed ID: 15137143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular immunity in tuberculosis].
    Matinca D; Făgărăşan S
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(4):269-77. PubMed ID: 9586339
    [No Abstract]   [Full Text] [Related]  

  • 8. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular and molecular nature of tubercular immunity in man].
    Crowle AJ; Douvas GS; May MH
    Bull Int Union Tuberc; 1983 Mar; 58(1):75-84. PubMed ID: 6412786
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of TB vaccines.
    Gupta UD; Katoch VM; McMurray DN
    Vaccine; 2007 May; 25(19):3742-51. PubMed ID: 17321015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Macrophage activity in anti-Mycobacterium immunity. II. Direct contact of Mycobacterium tuberculosis with the macrophage].
    Lipińska R
    Pneumonol Pol; 1982 Oct; 50(10):535-9. PubMed ID: 6820496
    [No Abstract]   [Full Text] [Related]  

  • 12. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive immunity to mycobacteria.
    Orme I
    Curr Opin Microbiol; 2004 Feb; 7(1):58-61. PubMed ID: 15036141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection.
    López Y; Yero D; Falero-Diaz G; Olivares N; Sarmiento ME; Sifontes S; Solis RL; Barrios JA; Aguilar D; Hernández-Pando R; Acosta A
    Int J Med Microbiol; 2009 Aug; 299(6):447-52. PubMed ID: 19157977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
    Romano M; Rindi L; Korf H; Bonanni D; Adnet PY; Jurion F; Garzelli C; Huygen K
    Vaccine; 2008 Nov; 26(48):6053-63. PubMed ID: 18822333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products.
    Dannenberg AM; Collins FM
    Tuberculosis (Edinb); 2001; 81(3):229-42. PubMed ID: 11466035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis.
    Yamamoto K; Granger DL; Brehmer W; Azuma I; Ribi E
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):127-41. PubMed ID: 6797153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased neutrophil influx but no impairment of protective immunity to tuberculosis in mice lacking the CD44 molecule.
    Kipnis A; Basaraba RJ; Turner J; Orme IM
    J Leukoc Biol; 2003 Dec; 74(6):992-7. PubMed ID: 12972514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the human immune response in tuberculosis.
    Tsuyuguchi I
    Infect Agents Dis; 1996 Mar; 5(2):82-97. PubMed ID: 8721045
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophages and Mycobacterium tuberculosis: the key to pathogenesis.
    Rook GA
    Immunol Ser; 1994; 60():249-61. PubMed ID: 8251572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.